Crossmark Global Holdings, Inc. Takeda Pharmaceutical CO LTD Transaction History
Crossmark Global Holdings, Inc.
- $6.02 Billion
- Q2 2025
A detailed history of Crossmark Global Holdings, Inc. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 727,194 shares of TAK stock, worth $10.2 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
727,194
Previous 396,833
83.25%
Holding current value
$10.2 Million
Previous $5.9 Million
90.54%
% of portfolio
0.19%
Previous 0.11%
Shares
22 transactions
Others Institutions Holding TAK
# of Institutions
368Shares Held
73.1MCall Options Held
1.68MPut Options Held
157K-
Capital Research Global Investors Los Angeles, CA13.3MShares$187 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.62MShares$107 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.5MShares$63.4 Million0.01% of portfolio
-
Ubs Group Ag4.02MShares$56.7 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.71MShares$52.3 Million0.54% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $43.8B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...